2022 Topics Include:
  • Policy Outlook: Reviewing the Biden Administration’s Healthcare Priorities 
  • Treating Cancer Through Precision Oncology
  • What is New in Cross-Pacific Deal-making and Investment?
  • Market Outlook—Gauging the Impact of Public Market Volatility on Private Equity Priorities 
  • Exploring the Possibilities of Developing Neurodegenerative Therapeutics
  • Venture Investment Trends in Biotech
  • Demonstrating Sustainability to ESG Investors
  • The Future of Corporate Governance: Implementing Change and Leading the Way 
  • Creating the Next Generation of Biotech Start-Ups through Incubators
  • The Promise of Protein Degradation in Treating Undruggable Targets
  • Strategic M&A Under Attack: Regulator Resistance and SPAC Competition

2022 BIO CEO & Investor Conference Schedule at a Glance

See 2021 Schedule & Agenda

Thursday, February 10 – Friday, February 11, 2022 (EST)
All Day Company Presentations Online: On Demand
Monday, February 14, 2022 (EST)  
7:30 AM – 6:00 PM  One-on-One Partnering Meetings 
 
In-Person 
9:00 AM – 11:30 AM  Company Presentations 

In-Person 

Online: On-Demand

9:00 AM – 5:00 PM Fireside Chats and Panel Sessions 

In-Person 

Online

9:00 AM – 6:00 PM  Company Presentations

In-Person 

Online: On-Demand

6:00 PM – 7:00 PM BIO CEO & Investor Welcome Reception  In-Person

 

Tuesday, February 15, 2022 (EST)  
7:00 AM – 5:30 PM  One-on-One Partnering Meetings  In-Person
9:00 AM – 4:30 PM  Company Presentations 

In-Person 

Online: On-Demand

10:00 AM – 3:00 PM  Fireside Chats and Panel Sessions 

In-Person 

Online

5:00 PM – 6:00 PM BIO CEO & Investor Closing Reception In-Person 

 

Wednesday, February 16, 2022 (EST)  
10:00 AM – 3:00 PM Fireside Chats and Panel Sessions Online
All Day  One-on-One Partnering Meetings Online
All Day Company Presentations  Online: On-Demand

 

Thursday, February 17, 2022 (EST)  
All Day One-on-One Partnering Meetings Online
All Day Company Presentations Online: On-Demand
All Day Fireside Chats and Panel Sessions Online: On-Demand

 

Statement on Diversity

BIO is committed to workforce development, diversity, and inclusion, and incorporates these values into all aspects of BIO operations. Program development for BIO’s events will be considered in this light, with specific attention paid to speakers’ gender, race, ethnic background, sexual orientation, and gender identity, as well as their company’s focus, financing, geographic location, and size.  Diverse programming at BIO’s events allows BIO to remain a strong leader in efforts to ensure that the biotechnology industry can attract, develop, and retain a high-quality, globally competitive employee talent pool. Learn more about Workforce Development, Diversity, & Inclusion at BIO.